October 11, 2016 – Vancouver, British Columbia – Vodis Pharmaceuticals Inc. (CSE:
VP / FSE: 1JV) ("Vodis" or the "Company") is very pleased to announce that Ivan
Miliovski who is one of the company's founders has moved from the interim CEO role
to full time CEO position. Additionally Vodis is very pleased to announce the
appointment of Mark Lotz as their CFO.

Mr Lotz is a Chartered Professional Accountant practicing publicly through his firm
Lotz CPA Inc. Having qualified in 1994 he brings a wealth of experience in business,
tax and consulting. Formerly a CEO and CFO in the brokerage industry, he also has
senior management experience in the mining, manufacturing and digital media
sectors. He provides strategic tax and business planning and is a sought after expert
for complex contractual issues and financial quantification. He regularly consults with
legal firms acting as an expert witness on matters of securities regulation and
litigation. He sits on the board of and is chair of the audit committees for a number of
public companies. In addition he serves as the CFO of TrackX Holdings Inc., the
Canadian parent of a U.S. based assets tracking solutions provider.
"Mark is an excellent addition to our team and will provide a key analytical approach
we need to develop and execute our business model. It's crucial as we expand our
business that we grow with the bottom line in mind and we establish a clear picture
of what true costs go into every dollar of revenue we can create." States CEO Ivan

For further information, please contact:

Ivan Miliovski
Chief Executive Officer and Chief Operating Officer
Vodis Innovative Pharmaceuticals Inc.
8788 River Rd, Delta, V4G 1B4, Canada
Cell: 778-242-9677
Website: www.vodis.ca

The Canadian Securities Exchange has neither approved nor disapproved the
contents of this news release and accepts no responsibility for the adequacy or
accuracy hereof.

Forward-Looking Information:
Certain information contained herein may constitute “forward-looking
information” under Canadian securities legislation. Generally, forward-looking
information can be identified by the use of forward-looking terminology such as
“expects” or “it is expected”, or variations of such words and phrases or
statements that certain actions, events or results “will” occur. Forward-looking
statements are based on the opinions and estimates of management as of the date
such statements are made and they are subject to known and unknown risks,
uncertainties and other factors that may cause the actual results, level of activity,
performance or achievements of the Company to be materially different from
those expressed or implied by such forward-looking statements or forward-looking
information, including: the use of proceeds of this financing. Although
management of the Company has attempted to identify important factors that
could cause actual results to differ materially from those contained in forwardlooking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not undertake to update any forward-looking statements or forward-looking information that is incorporated by reference herein, except as required by applicable securities laws.





Jordana Casey

  • Page 1 of 61